NALDINI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 16.830
EU - Europa 13.554
AS - Asia 6.976
SA - Sud America 1.109
AF - Africa 131
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 10
Totale 38.641
Nazione #
US - Stati Uniti d'America 16.639
GB - Regno Unito 3.098
CN - Cina 2.979
RU - Federazione Russa 2.717
SG - Singapore 2.244
IE - Irlanda 1.928
UA - Ucraina 1.262
SE - Svezia 1.086
IT - Italia 971
BR - Brasile 960
DE - Germania 959
FR - Francia 738
HK - Hong Kong 542
FI - Finlandia 455
KR - Corea 447
VN - Vietnam 243
IN - India 141
CA - Canada 98
TR - Turchia 70
MX - Messico 66
BD - Bangladesh 64
ES - Italia 62
JP - Giappone 62
AR - Argentina 50
PL - Polonia 45
ZA - Sudafrica 39
CZ - Repubblica Ceca 36
NL - Olanda 33
EC - Ecuador 32
AU - Australia 28
BE - Belgio 27
IQ - Iraq 25
PK - Pakistan 25
AT - Austria 24
MA - Marocco 22
CI - Costa d'Avorio 19
UZ - Uzbekistan 19
VE - Venezuela 17
CO - Colombia 16
CL - Cile 14
RO - Romania 14
AE - Emirati Arabi Uniti 13
DK - Danimarca 13
ID - Indonesia 12
KE - Kenya 12
LT - Lituania 12
SA - Arabia Saudita 12
EG - Egitto 11
CH - Svizzera 9
JO - Giordania 9
EU - Europa 8
HU - Ungheria 8
TN - Tunisia 8
AZ - Azerbaigian 7
BO - Bolivia 7
JM - Giamaica 7
KZ - Kazakistan 7
EE - Estonia 6
IR - Iran 6
PY - Paraguay 6
AL - Albania 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
GR - Grecia 5
IL - Israele 5
LV - Lettonia 5
NO - Norvegia 5
BY - Bielorussia 4
KG - Kirghizistan 4
LU - Lussemburgo 4
MY - Malesia 4
PH - Filippine 4
PT - Portogallo 4
TH - Thailandia 4
TW - Taiwan 4
AM - Armenia 3
BG - Bulgaria 3
ET - Etiopia 3
GT - Guatemala 3
LB - Libano 3
NP - Nepal 3
OM - Oman 3
RS - Serbia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BB - Barbados 2
BN - Brunei Darussalam 2
CG - Congo 2
GA - Gabon 2
HN - Honduras 2
HR - Croazia 2
IM - Isola di Man 2
MD - Moldavia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
QA - Qatar 2
SN - Senegal 2
SY - Repubblica araba siriana 2
Totale 38.616
Città #
Southend 2.847
Menlo Park 2.481
Dallas 2.160
Dublin 1.920
Singapore 1.365
Chandler 1.184
Fairfield 1.082
Jacksonville 1.038
Ashburn 951
Beijing 797
Santa Clara 788
Moscow 718
Hong Kong 541
Wilmington 539
Woodbridge 510
Ann Arbor 500
Seoul 447
Hefei 434
Cambridge 406
Houston 401
Seattle 401
Nanjing 355
Princeton 339
Siena 314
Los Angeles 205
Helsinki 179
Boardman 176
New York 160
Munich 152
The Dalles 130
Buffalo 117
Nanchang 115
San Mateo 97
San Diego 83
São Paulo 82
Shanghai 80
Shenyang 80
Ho Chi Minh City 78
Milan 77
Dearborn 71
Tianjin 63
Kunming 58
London 56
Changsha 52
Hebei 52
Turku 52
Redondo Beach 49
Bengaluru 48
Jiaxing 47
Rome 47
Council Bluffs 46
Fremont 45
Tokyo 45
Düsseldorf 44
Redwood City 44
Dong Ket 41
Florence 37
Hanoi 37
Frankfurt am Main 36
Málaga 36
Brooklyn 35
Norwalk 35
Jinan 34
San Francisco 34
Warsaw 33
Toronto 32
Izmir 31
Montreal 31
Zhengzhou 31
Chicago 30
Columbus 30
Phoenix 30
Rio de Janeiro 29
Venezia 29
Atlanta 28
Chennai 28
Guangzhou 28
Ningbo 27
Hangzhou 26
Prato 26
Washington 26
Belo Horizonte 25
Brussels 25
Olomouc 24
Stockholm 24
Renton 22
Dhaka 21
Johannesburg 21
Curitiba 20
Denver 20
Abidjan 19
Orem 19
Tashkent 18
Manchester 17
Amsterdam 16
Boston 16
Lappeenranta 16
San Jose 16
Taizhou 15
Poplar 14
Totale 26.336
Nome #
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors 382
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors 330
The Shc protein RAI promotes an adaptive cell survival program in hypoxic neuroblastoma cells 313
Different adaptive responses to hypoxia in normal and multiple myeloma endothelial cells 306
Novel acylguanidine derivatives targeting smoothened induce antiproliferative and pro-apoptotic effects in chronic myeloid leukemia cells 306
Adaptative cellular responses to hypoxia: role of HIF-1 dependent genes in endothelial cell autophagy and survival 281
Short-term hypoxia enhances the migratory capability of dendritic cell through HIF-1α and PI3K/Akt pathway 280
Administration of interferons and interleukin 2 via the lymphatic route 279
Design, synthesis, biological activity and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study 274
N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a scaffold for the synthesis of inhibitors of Bcr-Abl 272
The adaptor protein p66Shc is a positive regulator in the angiogenic response induced by hypoxic T cells 266
Analysis of protease-activated receptor-1 and -2 in human scar formation 264
Different Expression of Hypoxic and Angiogenic Factors in Human Endometriotic Lesions 262
A Ribonuclease Protection Assay-Based Approach for Analysis of Angiogenic Gene Expression in Archival Tissues 262
The Shc protein Rai enhances T-cell survival under hypoxia 258
Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma 253
Cell growth inhibition by interferon in hypoxia 249
Concentrazioni plasmatiche e tissutali di interferone in pazienti sottoposti a resezione chirurgica per cancro polmonare 248
Administration of the interferons via the lymphatic route 245
Identification of thrombin-like activity in ovarian cancer associated ascites and modulation of multiple cytokine networks 243
Hydroxylase Inhibition Selectively Induces Cell Death in Monocytes 243
Thrombin regulates the expression of pro-angiogenic cytokines via proteolytic activation of protease-activated receptor-1 242
Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs 237
Neuroglobin in Breast Cancer Cells: Effect of Hypoxia and Oxidative Stress on Protein Level, Localization, and Anti-Apoptotic Function 236
Carbonic anhydrase XII expression is linked to suppression of Sonic hedgehog ligand expression in triple negative breast cancer cells 235
Inhibition of smoothened in breast cancer cells reduces CAXII expression and cell migration 234
The adaptor protein p66shc is a positive regulator in the angiogenic response induced by hypoxic T cells 232
Effects of astrocytoma cells conditioned medium on differentiated neuroblastoma cells subjected to hypoxia and reperfusion 232
Alanine kinetics in humans during low-intensity exercise 229
Fisiologia Renale in Fisiologia Medica di Ganong 13 edizione italiana 225
Hypoxia affects dendritic cell survival: Role of the hypoxia-inducible factor-1α and lipopolysaccharide 224
Thrombin-mediated IL-10 up-regulation involves protease-activated receptor (PAR)-1 expression in human mononuclear leukocytes 224
Hypoxia and immune surveillance: role of the adaptor protein p66ShcA in negative regulation of T-cell activation and survival ' 224
Dendritic cell-derived VEGF-A plays a role in inflammatory angiogenesis of human secondary lymphoid organs and is driven by the coordinated activation of multiple transcription factors 224
Downregulation of hypoxia-related responses by novel antitumor histone deacetylase inhibitors in MDAMB231 breast cancer cells 223
Colorectal administration of human interferon -alpha 222
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation 221
L'ipossia induce l'espressione del recettore attivato da proteasi-1(PAR-1) nelle cellule MDA-MB-231 mediante l'accumulo del fattore indotto dall'ipossia-1alfa 217
Bulk preparation of hepatic binding protein 216
Hypoxia Shapes Autophagy in LPS-Activated Dendritic Cells 216
Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes 215
Thrombin enhancement of interleukin-1 expression in mononuclear cells: involvement of proteinase-activated receptor-1 214
New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation 214
Pyrazolo[3,4-d]pyrimidines Endowed with Antiproliferative Activity on Ductal Infiltrating Carcinoma Cells 211
Role of inflammatory mediators in angiogenesis 210
Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype 210
In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary by-pass 208
Distribution of human recombinant interferon-alpha 2 in rat plasma, liver, and experimental liver metastases 205
Interleukin 10 production in patients undergoing cardiopulmonary bypass: evidence of inhibition of th-1-type responses 203
Analysis of HIF-1 alpha and HIF-2 alpha in dendritic cells stimulated under hypoxic conditions 203
Inhibition of melanoma cell migration and invasion targeting the hypoxic tumor associated caxii 203
Hypoxia induces the expression and release of interleukin 1 receptor antagonist in mitogen-activated mononuclear cells 202
The effects of autologous platelet gel on inflammatory cytokine response in human peripheral blood mononuclear cells 199
HIF-1 upregulation by IL-1 contributes to the migratory potential of breast cancer cells 199
GM-CSF inhibits c-Kit and SCF expression by bone marrow-derived dendritic cells 199
Plasma levels of immunosuppressive mediators during cardiopulmonary bypass 199
‘HIF-1 dependent adaptative responses to hypoxia: pro-survival and pro-apoptotic signaling pathways 196
Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells 195
Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma 195
Regulation of angiogenesis by Th1- and Th2-type cytokines 193
Thrombin inhibits IFN-gamma production in human peripheral blood mononuclear cells by promoting a Th2 profile 192
Hypoxia induces the expression of protease-activated receptor (PAR)-1 through the hypoxic inducible factor (HIF)-1alpha in breast cancer cells 190
Hypoxia affects cytokine production and proliferative responses by human peripheral mononuclear cells 190
Different expression of cytokines and receptors in bleomycin-sensitive and resistant mice 187
Alpha-thrombin reverses differentiation-related changes in expression of P21CIP1/WAF1 in interferon-gamma differentiated monocytic cells 187
Pro·angiogenic signaling in neuroblastoma: interplay between HIF-1a and Shc C adaptor protein 187
Interferon (IFN) levels in human pulmonary tumors 186
Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanism 186
Structure-Based Optimization of Pyrazolo[3,4-d]pyrimidines as Abl Inhibitors and Antiproliferative Agents toward Human Leukemia Cell Lines. 184
The possible role of T cells and neutrophils in the regulation of tumour angiogenesis 183
Interleukin-1β Affects MDAMB231 Breast Cancer Cell Migration under Hypoxia: Role of HIF-1αand NFκB Transcription Factors 182
Inhibition of interleukin-12 expression by alpha-thrombin in human peripheral blood mononuclear cells: a potential mechanism for modulating Th1/Th2 responses 181
Hypoxia induces the expression of protease-activated receptor (PAR)-1 through the hypoxic inducible factor (HIF)-1α in MDA-MB-231 breast cancer cells 181
Thrombin enhances T cell proliferative responses and cytokine production 179
Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation 179
p66Shc is involved in promoting HIF-1alpha accumulation and cell death in hypoxic T cells 179
Human alpha-Thrombin Stimulates Proliferation of Interferon-gamma Differentiated, Growth-Arrested, U937 Cells, Overcoming Differentiation-Related Changes in Expression of p21CIP1/WAF1 and Cyclin D1 177
Cytokine expression in bleomycin-sensitive and resistant mice 177
Heparin coating of extracorporeal circuits inhibits cytokine release from mononuclear cells during cardiac operations 177
Regulation of the hypoxia-inducible factor (HIF)-1α by interleukin-1: implication for breast cancer cell migration in the tumor microenvironment 176
Thrombin modulation of natural killer activity in human peripheral lymphocytes 175
Role of p52RAI Shc protein in the adaptive response to hypoxia in T cells 175
Role of the hypoxic microenvironment in the antitumor activity of tyrosine kinase inhibitors 175
Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach 174
Plasma kinetics, distribution and fate of tumor necrosis factor 174
Studies for the evaluation of oxygenation and ozonation of blood during extracorporeal circulation 173
The thrombin peptide, TP508, enhances cytokine release and activates signaling events 173
Angiogenesis in tissue hypoxia 172
Use of interferons in ginecology 172
Hypoxia enhances the antiviral activity of interferons 172
CA-IX-Expressing Small Extracellular Vesicles (sEVs) Are Released by Melanoma Cells under Hypoxia and in the Blood of Advanced Melanoma Patients 171
Studies on tumor necrosis factor (TNF)- I. Pharmacokinetics of human recombinant TNF in rabbits and monkeys after intravenous administration 171
Protease-activated receptor-1 and tumor microenvironment: new insights in the inflammation-tumor progression network 171
Human alpha-thrombin as a growth factor: enhancement of T lymphocyte proliferative responses 171
Interferon levels in human pulmonary tumors are lower than plasma levels 169
Inhibition of Bcr-Abl phosphorylation and induction of apoptosis by pyrazolo[3,4-d] pyrimidines in human leukemia cells 169
PAR-2 is downregulated in keratinocytes from vitiligo lesions 168
Thrombin receptor expression and responsiveness of human monocytic cells to thrombin is linked to interferon-induced cellular differentiation 167
Hypoxia induces autophagy in human monocyte-derived dendritic cells: involvement of Class III PI3K/VPS34 164
p66Shc promotes apoptosis and antagonises mitogenic signaling in T cells. 164
Totale 21.282
Categoria #
all - tutte 115.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.547


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.288 0 0 0 0 0 340 112 489 523 326 301 197
2021/20222.422 153 303 138 263 112 35 105 188 117 232 189 587
2022/20234.268 264 265 652 625 450 851 62 332 475 69 145 78
2023/20242.817 115 71 236 127 111 762 1.004 102 14 49 30 196
2024/20255.722 134 336 539 272 777 256 130 335 448 202 608 1.685
2025/20269.163 1.062 2.000 1.723 1.413 2.672 293 0 0 0 0 0 0
Totale 38.797